RA in detail: beyond basic anti-inflammatory-inflammation-natural-remedy">inflammation
Rheumatoid arthritis (RA) affects 0.5-1% of the Belgian population (~60,000 people). It is not simply "joint inflammation"—it is a complex systemic autoimmune disease with:
- Th17 (pro-inflammatory) / Treg (regulatory) imbalance → uncontrolled auto-ginger and immunity
- Hyperproliferative FLS (fibroblast-like synoviocytes) (mediated by PDGF, IL-6)
- Cartilage destruction mediated by MMP-3, MMP-9, cathepsins
- Pannus formation (invasive synovial tissue activated by VEGF, PDGF)
- Extra-articular manifestations: cardiovascular, pulmonary, ocular
Advanced mechanisms of ginger in RA
1. Rebalancing Th17/Treg
In RA, Th17 lymphocytes (IL-17 producers) are in excess, while Treg (immunoregulatory) are deficient. 6-gingerol has been shown to:
- Inhibit Th17 differentiation (by reducing RORγt and STAT3)
- Promote Treg differentiation (by activating FOXP3 and the low mTOR pathway)
- Reduce IL-17A, IL-17F and IL-22 secreted by Th17
- Increase IL-10 secreted by Treg
2. Inhibition of IL-17 (central axis of RA)
IL-17 is the master cytokine in RA: it stimulates FLS to produce IL-6, GM-CSF, MMP-3, RANKL → bone and cartilage destruction. Anti-IL-17 biologics (secukinumab) are the reference treatments for resistant RA. Ginger reduces IL-17 via inhibition of STAT3 and RORγt in Th17.
3. Inhibition of PDGF (anti-synovial proliferation)
PDGF (Platelet-Derived Growth Factor) is the main proliferation factor for FLS → pannus formation → cartilage invasion. 6-gingerol inhibits PDGF-Rα and PDGF-Rβ receptors via suppression of PI3K/Akt signaling → slowing of pannus progression.
4. Inhibition of MMPs (cartilage protection)
MMP-3 (stromelysin-1) and MMP-9 (gelatinase B) are the main enzymes for cartilage destruction in RA. Ginger inhibits their expression via NF-κB (MMP-3) and AP-1 (MMP-9) → less joint destruction.
5. Inhibition of VEGF (anti-synovial angiogenesis)
VEGF in RA synovium creates neovascularization that supplies nutrients to the pannus. Ginger inhibits VEGF via HIF-1α (inhibited by Nrf2) and NF-κB → less synovial vascularization → slowing of progression.
| Target | Role in RA | Ginger effect |
|---|---|---|
| Th17/Treg ratio | Imbalance → autoimmunity | Normalization via RORγt ↓ / FOXP3 ↑ |
| IL-17A/F | Master cytokine → FLS activation | ↓ via STAT3 and RORγt modulation |
| PDGF-R | FLS proliferation → pannus | ↓ PI3K/Akt → slowed pannus |
| MMP-3 / MMP-9 | Cartilage destruction | ↓ via NF-κB and AP-1 |
| VEGF | Synovial neovascularization | ↓ via HIF-1α and NF-κB |
| TNF-α / IL-1β | Major pro-inflammatory cytokines | ↓ via NF-κB and NLRP3 |
| RANKL (synovial) | Periarticular bone resorption | ↓ via NF-κB → OPG ↑ |
GIMBER and RA: a counterproductive combination
GIMBER contains ~35g of sugar/100ml. Sugar exacerbates RA via:
- Systemic NF-κB activation → ↑ TNF-α, IL-6, IL-17 → exacerbation of Th17 response
- AGE generation → RAGE activation → NF-κB → amplification of autoimmunity
- Promotion of obesity (AMPK ↓) → pro-inflammatory adipose tissue → ↑ leptin, adipokines → activated Th17
- Correlation: RA patients who consume more sugar have higher activity scores (DAS28)
❓ FAQ — Ginger and rheumatoid arthritis
Q: Does ginger replace DMARDs or biologics in RA?
A: No. DMARDs (methotrexate) and biologics (anti-TNF, anti-IL-17) are essential in moderate to severe RA. Ginger can be used as a supplement to reduce residual inflammation. Always consult a rheumatologist.
Q: Are there clinical studies on ginger and RA?
A: Yes. A meta-analysis (Zhu 2015) shows a reduction in joint pain and CRP in RA patients with 3g/day of ginger vs placebo. The Th17/Treg mechanisms are mainly described in preclinical studies.
Q: Does GIMBER worsen RA?
A: The sugar in GIMBER (NF-κB activator, AGE promoter) is pro-inflammatory and counterproductive in RA. RA patients should avoid sugary drinks and choose sugar-free alternatives.
Related articles
To delve deeper into the topic, also read:
- ginger psoriasis-avance-vitiligo-lichen-plan-il-17-nrf2-melanocytes-inti">Ginger and autoimmune skin diseases: advanced psoriasis, vitiligo and lichen plan — IL-17, Nrf2 and melanocytes
- Ginger and psoriatic arthritis: IL-17, IL-23, TNF-α and enthesitis — immuno-inflammatory mechanisms
- ginger Crohn-rch-nf-kb-mucosal-th17-treg-nlrp3-tight-junctions-butyrate-inti">Ginger and inflammatory bowel diseases: Crohn's, UC and mucosal NF-κB — Th17/Treg and NLRP3
- thyroide-hashimoto-hypothyroidie-nodules-nf-kb-th17-treg-tpo-nrf2-inti">Ginger and thyroid: Hashimoto's, hypothyroidism and nodules — NF-κB, Th17/Treg and TPO
- Ginger and psoriasis: naturally reducing plaques, IL-17/IL-23 inflammation and itching
- Advanced psoriasis in Belgium: sugar, IL-17, Th17 and ginger (2025)
- Psoriasis in Belgium: sugary drinks, gut-skin axis and ginger as an anti-IL-17
- Ginger and autoimmune diseases: rheumatoid arthritis, lupus, MS — NF-κB, Treg and pro-inflammatory sugar